Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1997-06-02
1999-08-24
Knode, Marian C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 47, 514 43, 514 45, 514221, 514258, 514261, 514270, 514282, 514399, 514653, 514731, 536 2713, 536 276, 536 2761, 536 2762, 536 2763, 536 2623, 536 2626, 536 267, A61K 3170
Patent
active
059424974
ABSTRACT:
A purine compound, which has a desired and an undesired effect when a dosage sufficient to induce the desired effect is administered to a mammal, is combined with a counteracting agent, wherein the counteracting agent can reduce the undesired effect when the combination containing an effective amount of the purine compound is administered to a mammal. In a preferred embodiment, an adenosine compound is combined in vitro with a catecholamine in a predetermined ratio to form an adenosine composition. Very high dosages of a purine compound, such as adenosine, ATP or their analogs can be administered to a mammal via administration of compositions containing the purine compound and a counteracting agent, while reducing the dangerous, undesired effects associated with administering the same dosage of purine compound without first combining it with the counteracting agent. New catecholamine compositions are also taught. The purine and catecholamine compositions of the present invention pioneer new therapies which take advantage of the diversity of physiological effects of purine and catecholamine compounds.
REFERENCES:
patent: 4088756 (1978-05-01), Voorhees
patent: 4514405 (1985-04-01), Irmscher et al.
patent: 4590180 (1986-05-01), Irmscher et al.
patent: 4605644 (1986-08-01), Foker
patent: 4673563 (1987-06-01), Berne et al.
patent: 4693996 (1987-09-01), Steffen
patent: 4880783 (1989-11-01), Mentzer, Jr. et al.
patent: 4880918 (1989-11-01), Rapaport
patent: 4980379 (1990-12-01), Belardinelli et al.
patent: 5049372 (1991-09-01), Rapaport
patent: 5070877 (1991-12-01), Mohiuddin et al.
patent: 5104859 (1992-04-01), Sollevi
patent: 5137712 (1992-08-01), Kask et al.
patent: 5206222 (1993-04-01), Forman et al.
patent: 5236908 (1993-08-01), Gruber et al.
patent: 5364862 (1994-11-01), Spada et al.
patent: 5679650 (1997-10-01), Fukunaga et al.
Hall et al., "Antiviral Drug and Interferon Combinations," Ch. 3 in Antiviral Agents: The Development and Assessment of Antiviral Chemotherapy, vol. II, H. J. Field (ed.), CRC Press, Boca Raton, FL, 1987, pp. 29-43 and 74-77.
Homeister et al., "Combined Adenosine and Lidocaine Administration Limits Myocardial Reperfusion Injury," Circulation, 82(2), 595-608 (1990).
Friedholm et al., "The Release of Adenosine and Inosine From Canine Subcutaneous Adipose Tissue by Nerve Stimulation and Noradrenaline," J. Physiol., 313, 351-367 (1981).
Lagercrantz et al., "Adenosine Surge at Birth," Abstract in Adenosine and Adenine Nucleotides, D. M. Paton (ed.), Taylor & Francis, 1988, p. 290.
Barraco, "Behavior Actions of Adenosine and Related Substances," Ch. 28 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 339-366.
Dragunow, "Adenosine and Epileptic Seizures,", Ch. 29 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 367-379.
Radulovacki, "Adenosine and Sleep," Ch. 30 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (Ed.), CRC Press, Boca Raton, FL, 1991, pp. 381-390.
Sawynok, "Adenosine and Pain," Ch. 31 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 391-400.
Ng et al., "Adenosine and Asthma," Ch. 32 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 403-412.
Marangos et al., "Adenosine-Based Therapeutics in Neurologic Disease," Ch. 33 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 413-422.
K. A. Rudolphi, "Manipulation of Purinergic Tone as a Mechanism for Controlling Ischemic Brain Damage," Ch. 34 in Adenosine and Adenine Nucleotides as Regulators of Cellular Function, J. W. Phillis (ed.), CRC Press, Boca Raton, FL, 1991, pp. 423-436.
Burnstock (I), "Overview--Purinergic Mechanisms," in Part I of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 1-18.
Pelleg et al., "Cardiac Effects of Adenosine and ATP," in Part I of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 19-30.
Burnstock (II), "Dual Control of Local Blood Flow by Purines," in Part I of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 31-45.
Williams, "Purine Nucleosides and Nucleotides as Central Nervous System Modulators, Adenosine as the Prototypic Paracrine Neuroactive Substance," in Part I of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 93-107.
Chaudry, "Use of ATP Following Shock and Ischemia," in Part I of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 130-141.
White at al., "Neural Release of ATP and Adenosine," in Part IV of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 287-299.
Kim et al., "ATP Effects on Secretion and Second Messenger Production in Bovine Chromaffin Cells," in Poster Papers section of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 435-436.
Forsyth et al., "Purine Modulation of Norepinephrine Release in the Rat Vas Deferens," in Poster Papers section of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 507-509.
Chau et al., "Norepinephrine and ATP as Cotransmitters in the Guinea Pig Portal Vein and Rabbit Saphenous Artery," in Poster Papers section of Biological Actions of Extracellular ATP, Annals N.Y. Acad. Sci., vol. 603, N.Y. Acad. Sci., New York, NY, 1990, pp. 510-512.
Dunwiddie, "Electrophysiological Aspects of Adenosine Receptor Function," Ch. 5 in Adenosine and Adenosine Receptors, M. Williams (ed.), Humana Press, 1990, Clifton, NJ, pp. 143-172.
Mullane et al., "Adenosine and Cardiovascular Function," Ch. 8 in Adenosine and Adenosine Receptors, M. Williams (ed.), Humana Press, 1990, Clifton, NJ, pp. 289-333.
Griffiths et al., "The Role of Adenosine in Respiratory Physiology," Ch. 10 in Adenosine and Adenosine Receptors, M. Williams (ed.), Humana Press, 1990, Clifton, NJ, pp. 381-422.
Jarvis et al., "Adenosine in Central Nervous System Function," Ch. 11 in Adenosine and Adenosine Receptors, M. Williams (ed.), Humana Press, 1990, Clifton, NJ. pp. 423-474.
Fredholm et al., "Mechanism(s) of Inhibition of Transmitter Release by Adenosine Receptor Activation," in Adenosine Receptors in the Nervous System, Ribeiro (ed.), Taylor & Francis, New York, 1989, pp. 123-130.
Kather, "Beta Adrenergic Receptor Mediated Stimulation of Adenine Nucleotide Catabolism and Purine Release in Human Adipocytes," Ch. 20 in Purines in Cellular Signaling, Jacobson et al. (eds.), Springer-Verlag, New York, 1990, pp. 120-125.
Williams, "Adenosine Receptors as Drug Targets: Fulfilling the Promise?" Ch. 27 in Purines in Cellular Signaling, Jacobson et al. (eds.), Springer-Verlag, New York, 1990, pp. 174-183.
Westfall et al., "Modulation of Norepinephrine Release by ATP and Adenosine," Ch. 38 in Purines in Cellular Signaling, Jacobson et al. (eds.), Springer-Verlag, New York, 1990, pp. 260-265.
Howell et al., "Mechanisms of Xanthine Actions in Models of Asthma," Ch. 54 in Purines in Cellular Signaling, Jacobson et al. (eds.), Springer-Verlag, New York, 1990, pp. 370-375.
Headrick et al., "Modulation of Cardiac Efficiency: A Role of Adenosine in Metabolism in Metabolically Stimulated Rat Heart," Abstract No. D21 in Purines in Cellular Signaling, Jacobson et al. (eds.), Springer-Verlag, New York, 1990, p. 408.
Moritoki, "Evidence for the Involvement of Cyclic GMP in Adenosine-Induced Vasodilation," Ch. 20 in Role of Adenosine and Adenine Nucleotides in the Biological System, Metabolism, Release, Transport, Receptors, Transduct
Fukunaga Alex S.
Fukunaga Atsuo F.
Crane L. Eric
Knode Marian C.
Schein, Esq. Daniel B.
LandOfFree
Purine compound and catecholamine compound containing compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Purine compound and catecholamine compound containing compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Purine compound and catecholamine compound containing compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-467106